The Class I recall, which is the most serious recall the FDA issues, comes after numerous adverse events and complications linked to the radiographic markers were reported.  

UPDATED: The alert pertains to the BioZorb and BioZorb LP radiographic markers, implanted in soft tissue to indicate the site for radiation therapy or other medical procedures. 

Women with dense breast tissue are less likely than normal-density peers to develop breast cancer between screening mammography exams.

Although studies have shown AI to be effective as a support tool, several have also highlighted issues related to the potential for bias in algorithms that have not been trained on diverse datasets. 

In individuals who have not completed a DEXA scan, head CT conducted for other reasons can offer insight into patients’ frontal bone density, a potential marker of osteoporosis.

The new research, presented during ARRS 2024 in Boston, suggests CVD risk models may need to include certain findings identified in routine mammograms. 

“These accomplishments deliver significant progress toward addressing President Biden’s goal to end cancer as we know it." 

A team of experts determined that correlating masses initially detected on MRI are significantly more likely to result in a cancer diagnosis than other common findings.